Connection

Cheng-Feng Qin to Female

This is a "connection" page, showing publications Cheng-Feng Qin has written about Female.
Connection Strength

0.100
  1. 25-Hydroxycholesterol is a potent SARS-CoV-2 inhibitor. Cell Res. 2020 11; 30(11):1043-1045.
    View in: PubMed
    Score: 0.012
  2. A Thermostable mRNA Vaccine against COVID-19. Cell. 2020 09 03; 182(5):1271-1283.e16.
    View in: PubMed
    Score: 0.012
  3. Development of an inactivated vaccine candidate for SARS-CoV-2. Science. 2020 07 03; 369(6499):77-81.
    View in: PubMed
    Score: 0.012
  4. Development of a chimeric Zika vaccine using a licensed live-attenuated flavivirus vaccine as backbone. Nat Commun. 2018 02 14; 9(1):673.
    View in: PubMed
    Score: 0.010
  5. Intranasal infection and contact transmission of Zika virus in guinea pigs. Nat Commun. 2017 11 21; 8(1):1648.
    View in: PubMed
    Score: 0.010
  6. Immunization with truncated envelope protein of Zika virus induces protective immune response in mice. Sci Rep. 2017 08 30; 7(1):10047.
    View in: PubMed
    Score: 0.010
  7. A DNA-based West Nile virus replicon elicits humoral and cellular immune responses in mice. J Virol Methods. 2011 Dec; 178(1-2):87-93.
    View in: PubMed
    Score: 0.006
  8. Impaired Cellular Immunity to SARS-CoV-2 in Severe COVID-19 Patients. Front Immunol. 2021; 12:603563.
    View in: PubMed
    Score: 0.003
  9. Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy. Science. 2020 09 25; 369(6511):1603-1607.
    View in: PubMed
    Score: 0.003
  10. Persistent Viral Presence Determines the Clinical Course of the Disease in COVID-19. J Allergy Clin Immunol Pract. 2020 09; 8(8):2585-2591.e1.
    View in: PubMed
    Score: 0.003
  11. Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals. Immunity. 2020 06 16; 52(6):971-977.e3.
    View in: PubMed
    Score: 0.003
  12. Structural basis for neutralization of Japanese encephalitis virus by two potent therapeutic antibodies. Nat Microbiol. 2018 03; 3(3):287-294.
    View in: PubMed
    Score: 0.002
  13. Characterization of a candidate tetravalent vaccine based on 2'-O-methyltransferase mutants. PLoS One. 2018; 13(1):e0189262.
    View in: PubMed
    Score: 0.002
  14. Phylogenetic and genetic characterization of a 2017 clinical isolate of H7N9 virus in Guangzhou, China during the fifth epidemic wave. Sci China Life Sci. 2017 12; 60(12):1331-1339.
    View in: PubMed
    Score: 0.002
  15. A peptide-based viral inactivator inhibits Zika virus infection in pregnant mice and fetuses. Nat Commun. 2017 07 25; 8:15672.
    View in: PubMed
    Score: 0.002
  16. Existing drugs as broad-spectrum and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction. Cell Res. 2017 Aug; 27(8):1046-1064.
    View in: PubMed
    Score: 0.002
  17. Vector competence and transovarial transmission of two Aedes aegypti strains to Zika virus. Emerg Microbes Infect. 2017 Apr 26; 6(4):e23.
    View in: PubMed
    Score: 0.002
  18. U4 at the 3' UTR of PB1 segment of H5N1 influenza virus promotes RNA polymerase activity and contributes to viral pathogenicity. PLoS One. 2014; 9(3):e93366.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.